<h4>Background</h4>The accumulation and aggregation of amyloid beta (A β )-a peptide fragment derived from the proteolytic processing of amyloid precursor protein (APP)-is a central pathological feature of Alzheimer's disease (AD) and a current target for disease-modifying therapies. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.